Siegfried Holding Beheer
Beheer criteriumcontroles 2/4
De CEO Siegfried Holding is Marcel Imwinkelried, benoemd in Jan2024, heeft een ambtstermijn van minder dan een jaar. bezit rechtstreeks 0.008% van de aandelen van het bedrijf, ter waarde CHF 359.64K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.6 jaar en 4.6 jaar.
Belangrijke informatie
Marcel Imwinkelried
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | less than a year |
| Eigendom CEO | 0.008% |
| Management gemiddelde ambtstermijn | 5.6yrs |
| Gemiddelde ambtstermijn bestuur | 4.6yrs |
Recente managementupdates
Recent updates
Siegfried Holding AG's (VTX:SFZN) Price In Tune With Earnings
Nov 09
Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Sep 12A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Aug 04Siegfried Holding AG (VTX:SFZN) Not Flying Under The Radar
Jun 17Siegfried Holding AG's (VTX:SFZN) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 12Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Mar 15Earnings Miss: Siegfried Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 23Siegfried Holding AG's (VTX:SFZN) Business Is Yet to Catch Up With Its Share Price
Jan 27Is Siegfried Holding AG (VTX:SFZN) Worth CHF840 Based On Its Intrinsic Value?
Jan 07Is Now The Time To Put Siegfried Holding (VTX:SFZN) On Your Watchlist?
Dec 02We Think Siegfried Holding (VTX:SFZN) Can Stay On Top Of Its Debt
Nov 13A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Sep 28Here's Why We Think Siegfried Holding (VTX:SFZN) Might Deserve Your Attention Today
Aug 16With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
May 13Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Apr 25With EPS Growth And More, Siegfried Holding (VTX:SFZN) Makes An Interesting Case
Jan 20Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Dec 28Here's Why Siegfried Holding (VTX:SFZN) Has Caught The Eye Of Investors
Oct 13Siegfried Holding (VTX:SFZN) Has A Pretty Healthy Balance Sheet
Sep 25Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Jun 24Siegfried Holding (VTX:SFZN) Seems To Use Debt Quite Sensibly
Apr 08Do Siegfried Holding's (VTX:SFZN) Earnings Warrant Your Attention?
Mar 21Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Dec 23Should You Be Adding Siegfried Holding (VTX:SFZN) To Your Watchlist Today?
Dec 05Here's Why Siegfried Holding (VTX:SFZN) Can Manage Its Debt Responsibly
Sep 19If You Like EPS Growth Then Check Out Siegfried Holding (VTX:SFZN) Before It's Too Late
Sep 01These 4 Measures Indicate That Siegfried Holding (VTX:SFZN) Is Using Debt Reasonably Well
Jun 11Here's Why We Think Siegfried Holding (VTX:SFZN) Is Well Worth Watching
May 25Is Siegfried Holding (VTX:SFZN) A Risky Investment?
Mar 03Shareholders Are Thrilled That The Siegfried Holding (VTX:SFZN) Share Price Increased 227%
Jan 18Do Fundamentals Have Any Role To Play In Driving Siegfried Holding AG's (VTX:SFZN) Stock Up Recently?
Dec 22
What Kind Of Shareholders Hold The Majority In Siegfried Holding AG's (VTX:SFZN) Shares?
Nov 25CEO
Marcel Imwinkelried (57 yo)
less than a year
Tenure
Mr. Marcel Imwinkelried serves as Chief Executive Officer at Siegfried Holding AG from 2024, was its Chief Operating Officer of Drug Products from October 1, 2021 until 2024 and served as its Chief Operati...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | geen gegevens | 0.0076% CHF 359.6k | |
| Chief Financial Officer | 7.5yrs | geen gegevens | 0.26% CHF 12.2m | |
| Chief Scientific Officer | 5.6yrs | geen gegevens | 0.049% CHF 2.3m | |
| General Counsel & Secretary | 5.8yrs | geen gegevens | geen gegevens | |
| Head of Corporate Communications | no data | geen gegevens | geen gegevens | |
| Chief Human Resources Officer | 1.3yrs | geen gegevens | 0.017% CHF 822.2k | |
| Chief Business Officer of Drug Substances & Drug Products | 3.8yrs | geen gegevens | 0.72% CHF 33.7m | |
| Head Global Quality Management DS - Zofingen | no data | geen gegevens | geen gegevens | |
| Chief Strategy Officer | 5.8yrs | geen gegevens | geen gegevens | |
| Head Regulatory Affairs - Site Zofingen | no data | geen gegevens | geen gegevens | |
| Head of Operations - Malta | no data | geen gegevens | geen gegevens | |
| Head Corporate Quality Systems - Global Quality Systems | no data | geen gegevens | geen gegevens |
5.6yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van SFZN is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.6 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Independent Non-Executive Chairman | 14.6yrs | CHF 484.81k | 0.48% CHF 22.4m | |
| Independent Non-Executive Director | 4.6yrs | CHF 227.31k | 0.022% CHF 1.0m | |
| Independent Non-Executive Director | 10.8yrs | CHF 220.91k | 0.081% CHF 3.8m | |
| Independent Non-Executive Vice Chairman | 8.8yrs | CHF 253.67k | 0.053% CHF 2.5m | |
| Independent Director | 2.6yrs | CHF 221.98k | 0.0085% CHF 400.1k | |
| Director | 1.6yrs | CHF 151.35k | 0.0046% CHF 215.8k | |
| Independent Director | 2.6yrs | CHF 216.70k | 0.0085% CHF 400.1k |
4.6yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van SFZN wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).